CRISPR Therapeutics AG (CRSP)
56.25
+0.95
(+1.72%)
USD |
NASDAQ |
Jan 13, 16:00
56.25
0.00 (0.00%)
After-Hours: 16:47
CRISPR Therapeutics Market Cap: 5.361B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 115.36B |
| Intellia Therapeutics, Inc. | 1.358B |
| Beam Therapeutics, Inc. | 3.507B |
| Novartis AG | 271.76B |
| BeOne Medicines Ltd. | 38.86B |
Market Cap Related Metrics
| PS Ratio | 128.30 |
| PEG Ratio | -0.1032 |
| Price to Book Value | 2.798 |
| Price | 56.25 |
| Earnings Yield | -9.92% |
| PEGY Ratio | -0.1032 |